[SLRX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
12-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 3.76%
YoY- 34.67%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 571 1,269 1,479 1,378 1,243 1,133 1,039 -32.93%
PBT -3,074 -1,852 -1,768 -1,717 -1,784 -2,084 -1,882 38.73%
Tax -42 47 10 -42 62 -286 1 -
NP -3,074 -1,852 -1,768 -1,717 -1,784 -2,084 -1,883 38.68%
Tax Rate - - - - - - - -
Total Cost 3,646 3,121 3,246 3,095 3,028 3,217 2,922 15.91%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -538.05 -145.95 -119.52 -124.55 -143.51 -183.95 -181.27 106.67%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -1.72 -1.52 -2.84 -2.39 -3.20 -5.46 -14.40 -75.77%
EPS Diluted -1.72 -1.52 -2.84 -2.39 -3.20 -5.46 -14.40 -75.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.